DK8791A - Acetyleniske imidazolderivater samt farmaceutisk praeparat indeholdende disse - Google Patents
Acetyleniske imidazolderivater samt farmaceutisk praeparat indeholdende disse Download PDFInfo
- Publication number
- DK8791A DK8791A DK008791A DK8791A DK8791A DK 8791 A DK8791 A DK 8791A DK 008791 A DK008791 A DK 008791A DK 8791 A DK8791 A DK 8791A DK 8791 A DK8791 A DK 8791A
- Authority
- DK
- Denmark
- Prior art keywords
- disorders
- methyl
- ethyl
- hydrogen
- acetylenic
- Prior art date
Links
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 4
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 3
- 208000024827 Alzheimer disease Diseases 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 208000035475 disorder Diseases 0.000 abstract 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 abstract 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 abstract 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 abstract 1
- 208000010412 Glaucoma Diseases 0.000 abstract 1
- 201000006347 Intellectual Disability Diseases 0.000 abstract 1
- 208000036626 Mental retardation Diseases 0.000 abstract 1
- 208000019430 Motor disease Diseases 0.000 abstract 1
- 206010039966 Senile dementia Diseases 0.000 abstract 1
- 229940035676 analgesics Drugs 0.000 abstract 1
- 239000000730 antalgic agent Substances 0.000 abstract 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 abstract 1
- 229910052794 bromium Inorganic materials 0.000 abstract 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 abstract 1
- 208000015114 central nervous system disease Diseases 0.000 abstract 1
- 229910052801 chlorine Inorganic materials 0.000 abstract 1
- 239000000460 chlorine Substances 0.000 abstract 1
- 239000000064 cholinergic agonist Substances 0.000 abstract 1
- 239000000812 cholinergic antagonist Substances 0.000 abstract 1
- 208000010877 cognitive disease Diseases 0.000 abstract 1
- 125000004122 cyclic group Chemical group 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 abstract 1
- 229910052731 fluorine Inorganic materials 0.000 abstract 1
- 239000011737 fluorine Substances 0.000 abstract 1
- 150000002460 imidazoles Chemical class 0.000 abstract 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 abstract 1
- 230000036997 mental performance Effects 0.000 abstract 1
- -1 methylamino, dimethylamino, methoxy Chemical group 0.000 abstract 1
- 210000001002 parasympathetic nervous system Anatomy 0.000 abstract 1
- 208000020016 psychiatric disease Diseases 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
- C07D233/61—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms not forming part of a nitro radical, attached to ring nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/68—Halogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Ophthalmology & Optometry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22357688A | 1988-07-25 | 1988-07-25 | |
| PCT/US1989/002537 WO1990001026A1 (en) | 1988-07-25 | 1989-06-14 | Acetylenic imidazoles having central nervous system activity |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK8791D0 DK8791D0 (da) | 1991-01-18 |
| DK8791A true DK8791A (da) | 1991-01-18 |
Family
ID=22837101
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK008791A DK8791A (da) | 1988-07-25 | 1991-01-18 | Acetyleniske imidazolderivater samt farmaceutisk praeparat indeholdende disse |
| DK038995A DK38995A (da) | 1988-07-25 | 1995-04-05 | Acetyleniske imidazolderivater samt farmaceutisk præparat indeholdende disse |
| DK038895A DK38895A (da) | 1988-07-25 | 1995-04-05 | Acetyleniske imidazolderivater samt farmaceutisk præparat indeholdende disse |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK038995A DK38995A (da) | 1988-07-25 | 1995-04-05 | Acetyleniske imidazolderivater samt farmaceutisk præparat indeholdende disse |
| DK038895A DK38895A (da) | 1988-07-25 | 1995-04-05 | Acetyleniske imidazolderivater samt farmaceutisk præparat indeholdende disse |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP0426714B1 (de) |
| JP (1) | JPH03506032A (de) |
| KR (1) | KR900701761A (de) |
| AT (1) | ATE136300T1 (de) |
| AU (1) | AU620894B2 (de) |
| DE (1) | DE68926165D1 (de) |
| DK (3) | DK8791A (de) |
| WO (1) | WO1990001026A1 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5137905A (en) * | 1988-10-27 | 1992-08-11 | The Upjohn Company | Heterocyclic acetylenic amines having central nervous system activity |
| US5550257A (en) * | 1991-04-24 | 1996-08-27 | American Cyanamid Company | Substituted oxotremorine derivatives |
| US5356885A (en) * | 1991-04-24 | 1994-10-18 | American Cyanamid Company | Substituted oxotremorine derivatives and pharmaceutical use thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1245743A (en) * | 1967-11-09 | 1971-09-08 | Astra Ab | Alkynyl lactams |
| EP0117462A3 (de) * | 1983-02-28 | 1986-08-20 | American Cyanamid Company | N-(2-4-(1H-Imidazol-1-yl)alkyl)arylamide |
| ZA84949B (en) * | 1983-04-06 | 1984-09-26 | American Cyanamid Co | Substituted-n-(2-4-(1h-imidazol-1-yl)alkyl)substituted amides |
-
1989
- 1989-06-14 AT AT89908358T patent/ATE136300T1/de not_active IP Right Cessation
- 1989-06-14 DE DE68926165T patent/DE68926165D1/de not_active Expired - Lifetime
- 1989-06-14 KR KR1019900700632A patent/KR900701761A/ko not_active Ceased
- 1989-06-14 WO PCT/US1989/002537 patent/WO1990001026A1/en not_active Ceased
- 1989-06-14 JP JP1507986A patent/JPH03506032A/ja active Pending
- 1989-06-14 AU AU38777/89A patent/AU620894B2/en not_active Ceased
- 1989-06-14 EP EP89908358A patent/EP0426714B1/de not_active Expired - Lifetime
-
1991
- 1991-01-18 DK DK008791A patent/DK8791A/da not_active Application Discontinuation
-
1995
- 1995-04-05 DK DK038995A patent/DK38995A/da not_active Application Discontinuation
- 1995-04-05 DK DK038895A patent/DK38895A/da not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JPH03506032A (ja) | 1991-12-26 |
| DK8791D0 (da) | 1991-01-18 |
| DK38995A (da) | 1995-04-05 |
| WO1990001026A1 (en) | 1990-02-08 |
| EP0426714A1 (de) | 1991-05-15 |
| AU620894B2 (en) | 1992-02-27 |
| AU3877789A (en) | 1990-02-19 |
| DK38895A (da) | 1995-04-05 |
| EP0426714B1 (de) | 1996-04-03 |
| KR900701761A (ko) | 1990-12-04 |
| DE68926165D1 (de) | 1996-05-09 |
| ATE136300T1 (de) | 1996-04-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0102084A2 (hu) | Kinolinszármazékok, eljárás előállításukra és a vegyületeket tartalmazó gyógyszerkészítmények | |
| ATE8874T1 (de) | Therapeutisch nuetzliche 1-alkyl-2-amino-tetralin- derivate. | |
| HUP0300846A2 (hu) | Imidazopirimidin- és triazolopirimidin-származékok, eljárás előállításukra és ilyen vegyületeket tartalmazó gyógyszerkészítmények | |
| SE0104334D0 (sv) | Therapeutic agents | |
| ATE173257T1 (de) | Heterocyclische verbindungen und ihre herstellung und verwendung | |
| HUP0202017A2 (hu) | Új vegyületek | |
| NO306677B1 (no) | Heterosykliske forbindelser, farmasöytiske preparater og anvendelse av en slik forbindelse til fremstilling av et medikament | |
| MA27079A1 (fr) | Derives 1, 6-naphthyridine et leur utilisation dans le traitement du diabete et de troubles associes | |
| AU4210989A (en) | Heterocyclic acetylenic amines having central nervous system activity | |
| KR900001693A (ko) | 아자사이클릭 화합물, 이의 제조방법 및 이의 용도 | |
| DK8791A (da) | Acetyleniske imidazolderivater samt farmaceutisk praeparat indeholdende disse | |
| DE68903019D1 (de) | 4,5,6,7-tetrahydroisothiazolo (4,5-c)pyridin-derivate und isomere. | |
| ATE160566T1 (de) | Amphotere tricyclische verbindungen als antihistaminische und antiallergische mittel | |
| IL101506A0 (en) | Use of 2-iminothiazolidin-4-one derivatives as novel pharmaceutical active ingredients | |
| BE1002181A3 (fr) | 3-(2-haloalkyl)-1,4-oxathiines et 2-(2-haloalkyl)-1,4-dithiines, de meme que le traitement de la leucemie et des tumeurs avec ces substances. | |
| NO985063L (no) | Pyridyl- og pyrimidyl-piperaziner i behandling av substansmisbruks forstyrr | |
| DK0853478T3 (da) | Nye N-acylerede 4-hydroxyphenylaminderivater med analgetiske egenskaber samt farmaceutiske sammensætninger indeholdende disse | |
| DK1192161T3 (da) | Chromeno[4,3,2-de]isoquinoliner som kraftige dopaminreceptorligander | |
| IE800900L (en) | Pyrrolidinyl-benzoic acid derivatives. | |
| ATE56705T1 (de) | Piperidinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate. | |
| KR920011491A (ko) | 헥사히드로-8-히드록시-2, 6-메타노-2h-퀴놀리진-3(4h)-온 및 관련 화합물의 특정 에스테르를 함유하는 인식 장애 치료용 제약 조성물 | |
| RU93005202A (ru) | Производные пиримидина и лекарственное средство | |
| IT1226277B (it) | Lattami n-sostituiti | |
| TH21983A (th) | อนุพันธ์ของควิโนลีน (2) | |
| TH30603A (th) | สารประกอบแบบใหม่ |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AHB | Application shelved due to non-payment |